Publication

Article

Pharmacy Times

Volume00

PANEL ENDORSES FLUMIST FOR YOUNG CHILDREN

The Advisory Committee on ImmunizationPractices has recommendedthe flu vaccine FluMist for use inchildren aged 2 to 5. The recommendationfollows an expanded approvalof the vaccine?s use in September bythe FDA.

The panel said the nasal influenzavaccine is an option and did not favorit over traditional flu shots. Childrenwith a history of asthma or wheezingshould get the flu shot, according tothe committee members. The panelalso voted for a government programthat pays for vaccines to extend itsFluMist coverage to the younger agegroup.

FluMist, made by MedImmune Inc,received FDA approval in 2003 for usein children ages 5 and older and inadults up to age 49.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs